We are live on ! Find out more
IMDZ

Immune Design Corp.
IMDZ

Delisted

IMDZ was delisted on the 1st of April, 2019.

62 hedge funds and large institutions have $275M invested in Immune Design Corp. in 2015 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

467% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 3

386% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 7

31% more capital invested

Capital invested by funds: $210M → $275M (+$65.6M)

29% more funds holding

Funds holding: 4862 (+14)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
62
Holders Change
+14
Holders Change %
+29.17%
% of All Funds
1.67%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
17
Increased
34
Reduced
7
Closed
3
Calls
Puts
Net Calls
Net Calls Change

IMDZ Hedge Fund Activity: Q2 2015 in Review

62 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q2 2015, worth a combined $275M — up 31% from $210M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new IMDZ positions and 3 closed out — a net gain of 14 holders — while 34 added to existing stakes and 7 trimmed.

The largest buyer was Sectoral Asset Management, adding an estimated $17.6M. The largest seller was ProQuest Associates IV, cutting an estimated $10.2M.

  • 62 institutional investors held Immune Design Corp. (IMDZ) as of Q2 2015, up from 48 in Q1 2015.
  • Funds reported $275M of Immune Design Corp. stock for Q2 2015, up 31% quarter-over-quarter.
  • 17 funds opened new Immune Design Corp. positions in Q2 2015 and 3 closed out, a net change of +14 holders.
  • The largest Immune Design Corp. buyer in Q2 2015 was Sectoral Asset Management, an estimated $17.6M added.
  • The largest Immune Design Corp. seller in Q2 2015 was ProQuest Associates IV, an estimated $10.2M sold.

Based on aggregated 13F filings for Q2 2015.